Usefulness of medication instruction sheets for sharing information on cancer chemotherapy within the health care team.
Antineoplastic Agents
/ administration & dosage
Dentists
/ statistics & numerical data
Drug Information Services
Drug Labeling
Hematopoietic Stem Cell Transplantation
/ methods
Humans
Neoplasms
/ drug therapy
Nurses
/ statistics & numerical data
Patient Care Team
/ standards
Physicians
/ statistics & numerical data
Surveys and Questionnaires
Journal
Die Pharmazie
ISSN: 0031-7144
Titre abrégé: Pharmazie
Pays: Germany
ID NLM: 9800766
Informations de publication
Date de publication:
01 09 2019
01 09 2019
Historique:
entrez:
6
9
2019
pubmed:
6
9
2019
medline:
15
7
2020
Statut:
ppublish
Résumé
Patients receiving cancer chemotherapy may experience a number of potentially severe adverse drug reactions. It is crucial for all members of the health care team to monitor the effect of medicines on the patient to ensure the safety and efficacy of the chemotherapy. The present study prepared medication instruction sheets (MISs) on hematological malignancy and conducted a questionnaire survey to verify their usefulness among physicians, dentists, and nurses. MISs were prepared for 103 chemotherapy and 44 pretreatment regimens for hematopoietic stem cell transplantation in the Department of Hematology at Kyushu University Hospital. Eight questions were prepared to investigate whether MISs could help physicians, dentists, and nurses manage cancer chemotherapy more safely, effectively, and efficiently, as well as in the sharing of information. A total of 35 medical staff working in inpatient wards, including 8 physicians, 3 dentists, and 24 nurses, participated in the questionnaire survey. All of the staff responded to the questionnaire survey, which showed that the MISs were favorably accepted by the participants. There was no negative opinion on the management of chemotherapy using the MISs. The MIS was a useful tool for sharing information on cancer chemotherapy between patients and medical staff and for enabling efficient management, thereby improving the safety and efficacy of treatment.
Identifiants
pubmed: 31484599
doi: 10.1691/ph.2019.9467
doi:
Substances chimiques
Antineoplastic Agents
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM